Annual EBIT
-$926.44 M
-$1.19 B-456.30%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual earnings before interest & taxes is -$926.44 million, with the most recent change of -$1.19 billion (-456.30%) on December 31, 2023.
- During the last 3 years, IRWD annual EBIT has fallen by -$1.06 billion (-769.69%).
- IRWD annual EBIT is now -456.30% below its all-time high of $260.02 million, reached on December 31, 2022.
Performance
IRWD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$26.79 M
+$442.00 K+1.68%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly earnings before interest & taxes is $26.79 million, with the most recent change of +$442.00 thousand (+1.68%) on September 30, 2024.
- Over the past year, IRWD quarterly EBIT has stayed the same.
- IRWD quarterly EBIT is now -67.85% below its all-time high of $83.31 million, reached on December 31, 2017.
Performance
IRWD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$103.70 M
-$14.98 M-12.62%
September 30, 2024
Summary
- As of February 20, 2025, IRWD TTM earnings before interest & taxes is $103.70 million, with the most recent change of -$14.98 million (-12.62%) on September 30, 2024.
- Over the past year, IRWD TTM EBIT has stayed the same.
- IRWD TTM EBIT is now -61.41% below its all-time high of $268.74 million, reached on March 31, 2023.
Performance
IRWD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IRWD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -456.3% | 0.0% | 0.0% |
| 3 y3 years | -769.7% | -51.7% | -55.3% |
| 5 y5 years | -492.3% | -51.7% | -55.3% |
IRWD EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -456.3% | at low | -64.4% | +102.5% | -61.4% | +110.6% |
| 5 y | 5-year | -456.3% | at low | -64.4% | +102.5% | -61.4% | +110.6% |
| alltime | all time | -456.3% | at low | -67.8% | +102.5% | -61.4% | +110.6% |
Ironwood Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $26.79 M(+1.7%) | $103.70 M(-12.6%) |
| Jun 2024 | - | $26.35 M(+123.6%) | $118.68 M(-112.1%) |
| Mar 2024 | - | $11.78 M(-69.6%) | -$982.05 M(+6.0%) |
| Dec 2023 | -$926.44 M(-456.3%) | $38.78 M(-7.2%) | -$926.84 M(+4.1%) |
| Sep 2023 | - | $41.77 M(-103.9%) | -$890.38 M(+3.4%) |
| Jun 2023 | - | -$1.07 B(-1703.9%) | -$861.12 M(-420.4%) |
| Mar 2023 | - | $66.99 M(-11.0%) | $268.74 M(+3.4%) |
| Dec 2022 | $260.02 M(+12.2%) | $75.24 M(+5.9%) | $260.02 M(+8.2%) |
| Sep 2022 | - | $71.03 M(+28.0%) | $240.22 M(+1.7%) |
| Jun 2022 | - | $55.48 M(-4.8%) | $236.28 M(-2.6%) |
| Mar 2022 | - | $58.27 M(+5.1%) | $242.49 M(+4.6%) |
| Dec 2021 | $231.81 M(+67.6%) | $55.44 M(-17.4%) | $231.81 M(+1.0%) |
| Sep 2021 | - | $67.09 M(+8.7%) | $229.46 M(+11.8%) |
| Jun 2021 | - | $61.69 M(+29.6%) | $205.24 M(+16.8%) |
| Mar 2021 | - | $47.59 M(-10.4%) | $175.71 M(+27.0%) |
| Dec 2020 | $138.34 M(+44.8%) | $53.10 M(+23.9%) | $138.34 M(-1.9%) |
| Sep 2020 | - | $42.86 M(+33.3%) | $141.08 M(+9.3%) |
| Jun 2020 | - | $32.16 M(+214.7%) | $129.02 M(+8.8%) |
| Mar 2020 | - | $10.22 M(-81.7%) | $118.57 M(+23.4%) |
| Dec 2019 | $95.55 M(-161.1%) | $55.84 M(+81.3%) | $96.10 M(+65.1%) |
| Sep 2019 | - | $30.80 M(+41.9%) | $58.22 M(-150.7%) |
| Jun 2019 | - | $21.71 M(-277.2%) | -$114.92 M(-24.1%) |
| Mar 2019 | - | -$12.25 M(-168.2%) | -$151.39 M(-12.5%) |
| Dec 2018 | -$156.42 M(+743.5%) | $17.96 M(-112.6%) | -$173.01 M(+60.7%) |
| Sep 2018 | - | -$142.34 M(+864.8%) | -$107.65 M(-1034.0%) |
| Jun 2018 | - | -$14.75 M(-56.4%) | $11.53 M(-229.5%) |
| Mar 2018 | - | -$33.87 M(-140.7%) | -$8.90 M(-52.0%) |
| Dec 2017 | -$18.55 M(-56.4%) | $83.31 M(-459.7%) | -$18.55 M(-82.5%) |
| Sep 2017 | - | -$23.16 M(-34.2%) | -$105.71 M(-0.3%) |
| Jun 2017 | - | -$35.18 M(-19.2%) | -$105.99 M(+28.2%) |
| Mar 2017 | - | -$43.52 M(+1030.0%) | -$82.68 M(+94.3%) |
| Dec 2016 | -$42.55 M | -$3.85 M(-83.6%) | -$42.55 M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$23.44 M(+97.4%) | -$42.76 M(-24.6%) |
| Jun 2016 | - | -$11.88 M(+250.3%) | -$56.69 M(-34.8%) |
| Mar 2016 | - | -$3.39 M(-16.4%) | -$86.96 M(-22.1%) |
| Dec 2015 | -$111.57 M(-33.8%) | -$4.06 M(-89.1%) | -$111.57 M(-20.3%) |
| Sep 2015 | - | -$37.37 M(-11.3%) | -$139.90 M(+0.5%) |
| Jun 2015 | - | -$42.15 M(+50.5%) | -$139.20 M(-8.5%) |
| Mar 2015 | - | -$28.00 M(-13.5%) | -$152.11 M(-9.7%) |
| Dec 2014 | -$168.45 M(-33.1%) | -$32.39 M(-11.7%) | -$168.45 M(-7.8%) |
| Sep 2014 | - | -$36.67 M(-33.4%) | -$182.75 M(-9.8%) |
| Jun 2014 | - | -$55.05 M(+24.2%) | -$202.59 M(-2.3%) |
| Mar 2014 | - | -$44.34 M(-5.0%) | -$207.37 M(-17.6%) |
| Dec 2013 | -$251.81 M(+247.0%) | -$46.69 M(-17.4%) | -$251.81 M(+1.1%) |
| Sep 2013 | - | -$56.51 M(-5.6%) | -$248.96 M(+71.9%) |
| Jun 2013 | - | -$59.83 M(-32.6%) | -$144.80 M(+15.1%) |
| Mar 2013 | - | -$88.78 M(+102.5%) | -$125.76 M(+73.3%) |
| Dec 2012 | -$72.56 M(+12.0%) | -$43.84 M(-192.0%) | -$72.56 M(+103.3%) |
| Sep 2012 | - | $47.65 M(-216.8%) | -$35.69 M(-65.7%) |
| Jun 2012 | - | -$40.79 M(+14.6%) | -$103.95 M(+26.6%) |
| Mar 2012 | - | -$35.59 M(+411.3%) | -$82.11 M(+26.2%) |
| Dec 2011 | -$64.79 M(+9.5%) | -$6.96 M(-66.2%) | -$65.07 M(-6.7%) |
| Sep 2011 | - | -$20.61 M(+8.8%) | -$69.74 M(+7.1%) |
| Jun 2011 | - | -$18.95 M(+2.2%) | -$65.10 M(+2.6%) |
| Mar 2011 | - | -$18.54 M(+59.4%) | -$63.46 M(+6.8%) |
| Dec 2010 | -$59.16 M(-1.4%) | -$11.63 M(-27.2%) | -$59.42 M(-13.2%) |
| Sep 2010 | - | -$15.98 M(-7.7%) | -$68.42 M(+12.7%) |
| Jun 2010 | - | -$17.31 M(+19.4%) | -$60.70 M(-2.0%) |
| Mar 2010 | - | -$14.50 M(-29.8%) | -$61.97 M(-6.2%) |
| Dec 2009 | -$59.98 M(+9.7%) | -$20.64 M(+149.9%) | -$66.05 M(+15.9%) |
| Sep 2009 | - | -$8.26 M(-55.5%) | -$56.98 M(+17.0%) |
| Jun 2009 | - | -$18.58 M(+0.0%) | -$48.72 M(+61.6%) |
| Mar 2009 | - | -$18.57 M(+60.4%) | -$30.15 M(+160.4%) |
| Dec 2008 | -$54.70 M(+3.4%) | -$11.58 M | -$11.58 M |
| Dec 2007 | -$52.90 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual EBIT year-on-year change?
- What is Ironwood Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly EBIT year-on-year change?
- What is Ironwood Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM EBIT year-on-year change?
What is Ironwood Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of IRWD is -$926.44 M
What is the all time high annual EBIT for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual earnings before interest & taxes is $260.02 M
What is Ironwood Pharmaceuticals annual EBIT year-on-year change?
Over the past year, IRWD annual earnings before interest & taxes has changed by -$1.19 B (-456.30%)
What is Ironwood Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of IRWD is $26.79 M
What is the all time high quarterly EBIT for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly earnings before interest & taxes is $83.31 M
What is Ironwood Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, IRWD quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Ironwood Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of IRWD is $103.70 M
What is the all time high TTM EBIT for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM earnings before interest & taxes is $268.74 M
What is Ironwood Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, IRWD TTM earnings before interest & taxes has changed by $0.00 (0.00%)